Clinical trials
Phase 3 Colonic Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 5 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Pfizer | 3 |
| Dominik Paul Modest | 1 |
| Federation Francophone de Cancerologie Digestive | 1 |
| GlaxoSmithKline | 1 |
| Hutchison Medipharma Limited | 1 |
| IFOM ETS - The AIRC Institute of Molecular Oncology | 1 |
| Incyte Corporation | 1 |
| Isofol Medical AB | 1 |
| Johann Wolfgang Goethe University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colonic Neoplasms | 24 |
| Colorectal Neoplasms | 15 |
| Rectal Neoplasms | 11 |
| Neoplasm Metastasis | 3 |
| Colonic Diseases | 2 |
| Digestive System Diseases | 2 |
| Digestive System Neoplasms | 2 |
| Gastrointestinal Diseases | 2 |
| Gastrointestinal Neoplasms | 2 |
| Intestinal Diseases | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.